Amendment 1 - Summary.pdf

This document provides details on Amendment 1 to a solicitation for the acquisition of medical countermeasures. The amendment extends the cutoff date for questions to July 29, 2021, changes the proposal submission deadline to September 3, 2021, and adjusts corresponding questionnaire and question deadlines.

The related federal contract opportunity is for the acquisition of medical countermeasures for pandemic influenza and emerging diseases preparedness and response. The base period of performance is 36 months from award date with two 12-month option periods. Services required include provision of influenza vaccine master seed lots, research lots, investigational lots, bulk lots, adjuvant bulk lots, formulation and filling, storage and stability testing, shipping, candidate vaccine virus, potency reagents and standards, analytical testing, non-clinical studies, clinical studies, disposal, and standard and additional reporting. Pricing is to be provided as firm-fixed-price for all contract line items except those specified as cost-reimbursable or to be determined. The minimum guarantee is $50,000 for the contract duration. The soliciting agency is the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response.